L. Wu

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

S. M. Park, M. N. Duy, Le Tuan Linh, 2019, Lancet.

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase 3 trial.

G. Lou, Q. Zhou, B. Kong, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

2LB Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who have previously received platinum- based chemotherapy (INTEREST)

Edward S. Kim, M. Socinski, T. Mok, 2007 .

Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer

S. Jiao, X. Yan, M. Zhang, 2021, ESMO open.

Clinical characteristics of patients with non-small cell lung cancers harboring anaplastic lymphoma kinase rearrangements and primary lung adenocarcinoma harboring epidermal growth factor receptor mutations.

J. Li, J. Lei, Q. Wang, 2015, Genetics and molecular research : GMR.

P3.15-06 Capillary Leak Syndrome in a Primary Lung Adenocarcinoma Patient with Thrombocytopenia from Interleukin-11 Treatment

M. Fang, You‐cai Zhu, K. Du, 2018, Journal of Thoracic Oncology.

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma.

W. Liang, X. Yi, T. Mok, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.